<DOC>
	<DOCNO>NCT01068483</DOCNO>
	<brief_summary>This first-in-man , phase I clinical research study BKM120 , potent highly specific oral pan-class I phosphatidylinositol-3-kinase ( PI3K ) inhibitor . The study consist dose escalation part follow MTD expansion part . Once MTD define , MTD expansion part open enrollment .</brief_summary>
	<brief_title>Safety BKM120 Monotherapy Advanced Solid Tumor Patients</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>All patient : Histologicallyconfirmed advance solid tumor Progressive , recurrent unresectable disease World Health Organization ( WHO ) Performance status ≤ 2 No history primary brain tumor brain metastasis MTD Expansion part : Histologicallyconfirmed advance solid tumor Progressive , recurrent unresectable disease World Health Organization ( WHO ) Performance status ≤ 2 No history primary brain tumor ; brain metastasis unless asymptomatic clinically stable ≥ 3 month Patients genetic molecular alteration PI3K pathway Prior treatment PI3K inhibitor History active major depressive episode , bipolar disorder , schizophrenia , history suicidal attempt ideation No clinically manifest diabetes mellitus ( treat and/or clinical sign ) No acute chronic renal disease No acute chronic liver disease No acute chronic pancreatitis No unresolved diarrhea No impaired cardiac function clinically significant cardiac disease ventricular arrhythmia , congestive heart failure , uncontrolled hypertension No acute myocardial infarction unstable angina pectoris within past 3 month Not pregnant nursing fertile patient must use barrier contraceptive Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Advanced solid tumor</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Colon Cancer</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Endometrium cancer</keyword>
</DOC>